scholarly journals Improvements on the purification of mannan-binding lectin and demonstration of its Ca2+-independent association with a C1s-like serine protease

1996 ◽  
Vol 319 (2) ◽  
pp. 329-332 ◽  
Author(s):  
Suet Mien TAN ◽  
Maxey C. M. CHUNG ◽  
Oi Lian KON ◽  
Steffen THIEL ◽  
Szu Hee LEE ◽  
...  

Mannan-binding lectin (MBL), previously called ‘mannan-binding protein’ or MBP, is a plasma C-type lectin which, upon binding to carbohydrate structures on micro-organisms, activates the classical pathway of complement. Purification of MBL relies on its Ca2+-dependent affinity for carbohydrate, but existing methods are susceptible to contamination by anti-carbohydrate antibodies. In the present study a sequential-sugar-elution method has been developed which can achieve a preparation of virtually pure MBL and its associated serine protease (MBL-associated serine protease, MASP) by two steps of affinity chromatography. In further separation of MASP from MBL, it was found that activated MASP was associated with MBL independent of Ca2+. Since MBL was found to bind to underivatized Sepharose 4B, the MBL-MASP complex was purified using Sepharose 4B and protease inhibitors were included to purify the complex with MASP in its proenzyme form. Analysis of thus-purified MBL-MASP complex by gel filtration on a Sephacryl S-300 column at pH 7.8 showed that the proenzyme MASP was also associated with MBL independently of Ca2+, but that the complex could be disrupted at a low pH (5.0). Therefore the mechanism of MBL-MASP-mediated complement activation appears to be significantly different from the C1-mediated classical pathway.

2009 ◽  
Vol 46 (8-9) ◽  
pp. 1696-1701 ◽  
Author(s):  
Anna St. Swierzko ◽  
Maciej Cedzynski ◽  
Iwona Domzalska-Popadiuk ◽  
Shirley L. MacDonald ◽  
Monika Borkowska-Klos ◽  
...  

2003 ◽  
Vol 31 (4) ◽  
pp. 763-767 ◽  
Author(s):  
J.C. Jensenius ◽  
P.H. Jensen ◽  
K. McGuire ◽  
J.L. Larsen ◽  
S. Thiel

Mannan-binding lectin (MBL) is a plasma protein involved in the innate immune response. It binds to a number of micro-organisms and promotes killing of these through complement activation either directly or through opsonization. Clinical evidence indicates that in a variety of situations genetically determined low MBL levels are associated with increased susceptibility to infections. Infusions of plasma-derived MBL into MBL-deficient individuals was found to be safe in preliminary trials, but we considered that sufficient production and product safety could only be achieved through synthesis of recombinant MBL. A transfected human cell line produces MBL showing the same biological activity as plasma-derived MBL, and an essentially identical profile on MS. The production has been scaled up and clinical trials will start this year.


Sign in / Sign up

Export Citation Format

Share Document